US FDA Approves Generic Hypertension Drug by Lupin
On July 25, 2022, the US Food and Drug Administration (FDA) approved Azilsartan Medoxomil tablets, a generic hypertension drug developed by Lupin is used to treat hypertension or high blood pressure. The product is a generic equivalent of Edarbi tablets, 40 and 80 mg, developed by Azurity Pharmaceuticals, Inc., and the drug is mainly used […]
Continue Reading